MarketCap
Zentalis Pharmaceuticals ZNTL
€ 1.85
-7.42%
Facebook
X
Telegram
Zentalis Pharmaceuticals EV | ZNTL
EV Jährlich Zentalis Pharmaceuticals
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 229 M | 249 M | 1.06 B | 1.06 B | 3.62 B | 1.44 B | -48.2 M | -16.5 M | - | - | - | - | - | - | - |
Jährliche Entwicklung
Kennzahlen zur Anzeige auswählen
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 3.62 B | -48.2 M | 948 M |
EV anderer Aktien in der Pharmaeinzelhändler
| Name | EV | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
 |
Supernus Pharmaceuticals
SUPN
|
3.38 B | $ 40.79 | 0.22 % | $ 2.3 B |  USA |
 |
Savara
SVRA
|
1.18 B | $ 4.53 | 7.23 % | $ 1.01 B | USA |
 |
China SXT Pharmaceuticals
SXTC
|
-22 M | $ 3.49 | -14.88 % | $ 2.37 M |  China |
 |
Takeda Pharmaceutical Company Limited
TAK
|
6.95 T | $ 20.45 | 1.01 % | $ 32.3 B |  Japan |
 |
Inozyme Pharma
INZY
|
44.3 M | - | - | $ 207 M | USA |
 |
BioCardia
BCDA
|
8.09 M | $ 0.89 | -3.28 % | $ 5.93 M | USA |
 |
CNS Pharmaceuticals
CNSP
|
-2.04 M | $ 4.53 | -8.85 % | $ 2.01 M | USA |
 |
Cocrystal Pharma
COCP
|
7.76 M | $ 0.97 | 2.11 % | $ 11 M | USA |
 |
Protara Therapeutics
TARA
|
208 M | $ 2.36 | 1.07 % | $ 101 M | USA |
 |
Tarsus Pharmaceuticals
TARS
|
2.95 B | $ 69.94 | 2.55 % | $ 2.92 B | USA |
 |
Idera Pharmaceuticals
IDRA
|
51.5 M | - | -23.04 % | $ 26.6 M | USA |
 |
Teva Pharmaceutical Industries Limited
TEVA
|
70.6 B | $ 40.03 | 1.57 % | $ 45.8 B |  Israel |
 |
Collegium Pharmaceutical
COLL
|
2.52 B | $ 23.21 | 1.09 % | $ 735 M | USA |
 |
NanoString Technologies
NSTG
|
655 M | - | -37.43 % | $ 5.1 M | USA |
 |
Corcept Therapeutics Incorporated
CORT
|
3.82 B | $ 87.25 | 1.62 % | $ 9.06 B | USA |
 |
TG Therapeutics
TGTX
|
4.67 B | $ 54.79 | 1.14 % | $ 7.91 B | USA |
 |
Humanigen
HGEN
|
60.3 M | - | -81.12 % | $ 4.28 M | USA |
 |
Sorrento Therapeutics
SRNE
|
471 M | - | -29.58 % | $ 126 M | USA |
 |
Surface Oncology
SURF
|
-40 B | - | - | $ 59.7 M | USA |
 |
Corbus Pharmaceuticals Holdings
CRBP
|
119 M | $ 4.0 | -1.36 % | $ 53.3 M | USA |
 |
Sierra Oncology
SRRA
|
197 M | - | -0.05 % | $ 1.34 B |  Canada |
 |
Tonix Pharmaceuticals Holding Corp.
TNXP
|
-61.5 M | $ 5.31 | 2.42 % | $ 45.2 M | USA |
 |
Atea Pharmaceuticals
AVIR
|
370 M | $ 4.16 | 2.97 % | $ 339 M | USA |
 |
Tenax Therapeutics
TENX
|
479 M | $ 1.65 | -4.07 % | $ 64.7 M | USA |
 |
Vaccinex
VCNX
|
6.94 M | - | -61.37 % | $ 654 K | USA |
 |
Trevi Therapeutics
TRVI
|
1.5 B | $ 12.51 | -0.83 % | $ 1.69 B | USA |
 |
Nymox Pharmaceutical Corporation
NYMX
|
26.1 M | - | -19.68 % | $ 18.4 M | Canada |
 |
Akero Therapeutics
AKRO
|
2.99 B | - | - | $ 3.67 B | USA |
 |
Taysha Gene Therapies
TSHA
|
1.23 B | $ 4.0 | 0.88 % | $ 1.28 B | USA |
 |
Jounce Therapeutics
JNCE
|
-73.6 M | - | - | $ 98.4 M | USA |
 |
Verona Pharma plc
VRNA
|
43.8 B | - | - | $ 69.7 B |  Britain |
 |
Corner Growth Acquisition Corp.
COOL
|
109 M | - | -0.89 % | $ 114 M | USA |
 |
Acorda Therapeutics
ACOR
|
-13.2 M | - | -24.86 % | $ 820 K | USA |
 |
CRISPR Therapeutics AG
CRSP
|
4.38 B | $ 49.0 | -0.79 % | $ 4.41 B |  Schweiz |
 |
Corvus Pharmaceuticals
CRVS
|
324 M | $ 10.44 | -0.9 % | $ 824 M | USA |
 |
UroGen Pharma Ltd.
URGN
|
1.12 B | $ 34.05 | -1.29 % | $ 1.64 B | Israel |
 |
Ampio Pharmaceuticals
AMPE
|
-1.05 M | - | -11.43 % | $ 502 K | USA |
 |
United Therapeutics Corporation
UTHR
|
22.8 B | $ 593.02 | 0.94 % | $ 26.3 B | USA |
 |
Vericel Corporation
VCEL
|
1.92 B | $ 42.99 | 1.08 % | $ 2.16 B | USA |
 |
Veracyte
VCYT
|
2.78 B | $ 48.22 | 0.61 % | $ 3.79 B | USA |
|
Champions Oncology
CSBR
|
102 M | $ 4.82 | 2.12 % | $ 66.7 M | USA |
 |
Mersana Therapeutics
MRSN
|
106 M | - | - | $ 3.56 B | USA |
 |
Vir Biotechnology
VIR
|
1.02 B | $ 11.02 | 4.27 % | $ 1.53 B | USA |
 |
Viking Therapeutics
VKTX
|
3.09 B | $ 24.23 | -0.72 % | $ 2.73 B | USA |
 |
CymaBay Therapeutics
CBAY
|
3.36 B | - | - | $ 3.45 B | USA |
 |
Freeline Therapeutics Holdings plc
FRLN
|
248 M | - | - | $ 384 M | Britain |
 |
Cabaletta Bio
CABA
|
253 M | $ 1.34 | -9.18 % | $ 135 M | USA |
 |
CytomX Therapeutics
CTMX
|
971 M | $ 2.23 | -4.09 % | $ 308 M | USA |
 |
Vanda Pharmaceuticals
VNDA
|
435 M | $ 3.95 | -1.62 % | $ 233 M | USA |
 |
Allakos
ALLK
|
31 K | - | - | $ 28.6 M | USA |